Abstract
Background
The association between open-angle glaucoma (OAG) and early-onset Alzheimer's disease (EOAD) remains unclear.
Objective
To investigate the association between OAG and EOAD.
Methods
We conducted a case-control study using a Japanese nationwide administrative claims database. Individuals aged 40–64 with a diagnosis of Alzheimer's disease (AD) and a prescription for AD medications were defined as EOAD cases (n = 2344). The index date was the first AD medication prescription. Controls (n = 9376) were matched to cases in a 4:1 ratio by age and sex using risk set sampling. OAG exposure was defined as a diagnosis ≥12 months before the index date. Conditional logistic regression was used to estimate odds ratios (ORs) and 95% confidence intervals (CIs).
Results
OAG was present in 15.8% of EOAD cases and 12.5% of controls. A significant association was observed between OAG and EOAD (OR, 1.22; 95% CI, 1.06–1.40; p = 0.006). EOAD was associated with diabetes (OR, 1.56; 95% CI, 1.37–1.77; p < 0.001), hypertension (OR, 1.15; 95% CI, 1.02–1.29; p = 0.021), depression (OR, 7.81; 95% CI, 6.76–9.02; p < 0.001), and excessive alcohol use (OR, 2.35; 95% CI, 1.72–3.21; p < 0.001). In sex-stratified analyses, the association between OAG and EOAD was significant in males (OR, 1.32; 95% CI, 1.09–1.60; p = 0.005) but not in females (OR, 1.11; 95% CI, 0.90–1.37; p = 0.321).
Conclusions
Individuals with OAG may be associated with an increased risk of EOAD, and careful monitoring of cognitive symptoms may help facilitate early detection and intervention.
Get full access to this article
View all access options for this article.
References
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
